Patrick W.B. Derksen

7.0k total citations · 1 hit paper
70 papers, 4.9k citations indexed

About

Patrick W.B. Derksen is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Patrick W.B. Derksen has authored 70 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 39 papers in Oncology and 16 papers in Cell Biology. Recurrent topics in Patrick W.B. Derksen's work include Wnt/β-catenin signaling in development and cancer (26 papers), Cancer Cells and Metastasis (24 papers) and HER2/EGFR in Cancer Research (8 papers). Patrick W.B. Derksen is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (26 papers), Cancer Cells and Metastasis (24 papers) and HER2/EGFR in Cancer Research (8 papers). Patrick W.B. Derksen collaborates with scholars based in Netherlands, Germany and United States. Patrick W.B. Derksen's co-authors include Jos Jonkers, Steven T. Pals, Marcel Spaargaren, John Zevenhoven, Eline van der Burg, Michiel de Bruin, Mark J. O’Connor, Miranda van Amersfoort, Niall M.B. Martin and Alan Lau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Patrick W.B. Derksen

67 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

2008 762 citations Patrick W.B. Derksen, Michiel de Bruin et al. profile →

Peers

Countries citing papers authored by Patrick W.B. Derksen

Since Specialization

Citations

This map shows the geographic impact of Patrick W.B. Derksen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick W.B. Derksen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick W.B. Derksen more than expected).

Fields of papers citing papers by Patrick W.B. Derksen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick W.B. Derksen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick W.B. Derksen. The network helps show where Patrick W.B. Derksen may publish in the future.

Co-authorship network of co-authors of Patrick W.B. Derksen

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick W.B. Derksen. A scholar is included among the top collaborators of Patrick W.B. Derksen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick W.B. Derksen. Patrick W.B. Derksen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Afadin loss induces breast cancer metastasis through destabilisation of E‐cadherin to F‐actin linkage 2025 ·The Journal of Pathology ·(unknown), Lotte Enserink, Noboru Ishiyama, (unknown), (unknown), Isaäc J. Nijman, (unknown), Carlos Caldas, René Bernards, P. J. van Diest, Matthias Christgen, Thijs Koorman, Patrick W.B. Derksen	1
2	The laminin–keratin link shields the nucleus from mechanical deformation and signalling 2023 ·Nature Materials ·Zanetta Kechagia, Pablo Sáez, Manuel Gómez‐González, (unknown), (unknown), (unknown), Ion Andreu, Thijs Koorman, Amy E. M. Beedle, Alberto Elósegui-Artola, Patrick W.B. Derksen, Xavier Trepat, Marino Arroyo, Pere Roca‐Cusachs	44
3	SKOR1 mediates FER kinase-dependent invasive growth of breast cancer cells 2023 ·Journal of Cell Science ·(unknown), (unknown), (unknown), Lotte Enserink, (unknown), Marten Hornsveld, Valerie G. Brunton, Patrick W.B. Derksen, (unknown)	6
4	Canonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological type 2023 ·The Journal of Pathology ·(unknown), François Richard, (unknown), Thijs Koorman, (unknown), (unknown), Juliet M. Daniel, Christine Desmedt, Patrick W.B. Derksen	3
5	Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer 2022 ·Oncogene ·(unknown), Thijs Koorman, (unknown), (unknown), (unknown), Lotte Enserink, Daan Visser, Sridevi Jaksani, (unknown), Elvira R. M. Bakker, François Richard, Andrew Tutt, (unknown), Amanda Fitzpatrick, Pere Roca‐Cusachs, P. J. van Diest, Christine Desmedt, Juliet M. Daniel, Clare M. Isacke, Patrick W.B. Derksen	17
6	FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer 2022 ·Cell Reports ·(unknown), Nalan Liv, (unknown), Mark Opdam, (unknown), (unknown), (unknown), Rutger C.C. Hengeveld, (unknown), Erik van Werkhoven, Harmjan R. Vos, Holger Rehmann, Boudewijn Burgering, Hendrika M. Oosterkamp, Susanne M.A. Lens, Judith Klumperman, Sabine C. Linn, Patrick W.B. Derksen	7
7	Spatial collagen stiffening promotes collective breast cancer cell invasion by reinforcing extracellular matrix alignment 2022 ·Oncogene ·Thijs Koorman, Karin A. Jansen, Antoine Khalil, (unknown), Daan Visser, (unknown), (unknown), (unknown), P. J. van Diest, Johan de Rooij, Patrick W.B. Derksen	89
8	FOXO Transcription Factors Both Suppress and Support Breast Cancer Progression 2018 ·Cancer Research ·Marten Hornsveld, Lydia M.M. Smits, Maaike Meerlo, Miranda van Amersfoort, Marian J.A. Groot Koerkamp, Dik van Leenen, (unknown), Frank C. P. Holstege, Patrick W.B. Derksen, Boudewijn Burgering, Tobias B. Dansen	60
9	Re-inforcing the cell death army in the fight against breast cancer 2018 ·Journal of Cell Science ·(unknown), Robert A. H. van de Ven, Patrick W.B. Derksen	19
10	p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis 2016 ·Nature Communications ·Robert A. H. van de Ven, (unknown), Danielle Park, Robert van Domselaar, Daniëlle de Jong, Károly Szuhai, Elsken van der Wall, Oscar M. Rueda, H. Raza Ali, Carlos Caldas, P. J. van Diest, Martin W. Hetzer, Erik Sahai, Patrick W.B. Derksen	22
11	Nuclear p120-catenin contributes to anoikis resistance of Lobular Breast Cancer through Kaiso-dependent Wnt11 expression 2015 ·Disease Models & Mechanisms ·Robert A. H. van de Ven, Milou Tenhagen, Wouter Meuleman, (unknown), Ron C.J. Schackmann, Patrick W.B. Derksen	25
12	Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer 2015 ·Molecular Imaging and Biology ·(unknown), Arthur L.L. Adams, Sabrina Oliveira, Bram Dorresteijn, Mohamed El Khattabi, Jeroen F. Vermeulen, Elsken van der Wall, Willem P.Th.M. Mali, Patrick W.B. Derksen, Paul J. van Diest, Paul M.P. van Bergen en Henegouwen	54
13	Lobular breast cancer: molecular basis, mouse and cellular models 2015 ·Breast Cancer Research ·Matthias Christgen, Patrick W.B. Derksen	43
14	Loss of p120-Catenin Induces Metastatic Progression of Breast Cancer by Inducing Anoikis Resistance and Augmenting Growth Factor Receptor Signaling 2013 ·Cancer Research ·Ron C.J. Schackmann, Sjoerd Klarenbeek, Eva J. Vlug, Suzan Stelloo, Miranda van Amersfoort, Milou Tenhagen, Tanya M. Braumuller, Jeroen F. Vermeulen, Petra van der Groep, Ton Peeters, Elsken van der Wall, P. J. van Diest, Jos Jonkers, Patrick W.B. Derksen	48
15	FER kinase promotes breast cancer metastasis by regulating α6- and β1-integrin-dependent cell adhesion and anoikis resistance 2013 ·Oncogene ·Iordanka A. Ivanova, Jeroen F. Vermeulen, Cihangir Mutlu Ercan, Julia M. Houthuijzen, (unknown), Eva J. Vlug, Elsken van der Wall, P. J. van Diest, Marc Vooijs, Patrick W.B. Derksen	60
16	Chemotherapy Enhances Metastasis Formation via VEGFR-1–Expressing Endothelial Cells 2011 ·Cancer Research ·Laura G.M. Daenen, Jeanine M.L. Roodhart, Miranda van Amersfoort, (unknown), Wijnand Roessingh, Laurien H. Ulfman, Patrick W.B. Derksen, Emile E. Voest	142
17	Fibroblast Growth Factor Receptor 1–Transformed Mammary Epithelial Cells Are Dependent on RSK Activity for Growth and Survival 2009 ·Cancer Research ·Wa Xian, Leontios Pappas, (unknown), Laura M. Selfors, Patrick W.B. Derksen, Michiel de Bruin, Nathanael S. Gray, Jos Jonkers, Jeffrey M. Rosen, Joan S. Brugge	61
18	Conditional mouse models of breast cancer 2005 ·Cancer Research ·Xiaoling Liu, Patrick W.B. Derksen, Bastiaan Evers, Henne Holstege, Hanneke van der Gulden, Paul Krimpenfort, Anton Berns, Jos Jonkers	1
19	Follicular Dendritic Cells Catalyze Hepatocyte Growth Factor (HGF) Activation in the Germinal Center Microenvironment by Secreting the Serine Protease HGF Activator 2005 ·The Journal of Immunology ·Esther P.M. Tjin, Richard J. Bende, Patrick W.B. Derksen, (unknown), Hiroaki Kataoka, Marcel Spaargaren, Steven T. Pals	23
20	Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus‐mediated expression of NK4 2004 ·The Journal of Gene Medicine ·Daniëlle A.M. Heideman, Victor W. van Beusechem, Elisabeth Bloemena, Peter J.F. Snijders, Mikael E. Craanen, G. Johan A. Offerhaus, Patrick W.B. Derksen, Michiel de Bruin, M.A. Witlox, (unknown), Chris J.L.M. Meijer, Winald R. Gerritsen	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact